Effect and safety of high-dose dienogest (20 mg/day) in the treatment of women with endometriosis
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Purpose Hormonal treatment of endometriosis is often continued for long periods and has the potential to affect many essential metabolic processes. The current study aimed to determine the effects and safety of high-dose dienogest as a medical endometriosis therapy.Methods The effects and safety of high-dose dienogest, 20-30 mg/day for 24 weeks, were examined in 21 women aged 18-52 years with laparoscopically and histologically proven endometriosis stage I-IV (according to revised American Society of Reproductive Medicine criteria). At baseline and week 24, sera were obtained and stored at -20°C prior to analysis.Results The study showed no clinically significant effect of high-dose dienogest on thyroid or adrenal function, electrolyte balance or haematopoiesis. High-dose dienogest therapy also had no appreciable effects on glucose and lipid metabolism, liver enzymes or haemostasis. For instance, although dienogest mediated small increases in the haemostatic variables prothrombin fragment 1 + 2, antithrombin III and protein C, final levels (at week 24) remained within normal reference ranges for these parameters. The exception was the HDL-3 cholesterol concentration at week 24 (0.97 mmol/l), which increased beyond the normal range of 0.28-0.64 mmol/l.Conclusions This investigation yielded a unique dataset on the safety of high-dose dienogest in endometriosis stage I-IV. High-dose dienogest (20-30 mg/day) had little influence upon all the parameters measured. It is therefore likely that lower doses of dienogest would have similarly neutral safety effects: an important consideration in the use of dienogest for the treatment of endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The lack of changes in laboratory parameters supports previous trials that investigated the metabolic effects of dienogest [13, 14, 16, 23].”
From Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment (2012) · cites this paper as [23]
Citations
Cites
Eskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
ESHRE guideline for the diagnosis and treatment of endometriosis
Kennedy, S., Bergqvist, A., Chapron, C., D’Hooghe, T., Dunselman, G., Greb, R., Hummelshoj, L., Prentice, A., & Saridogan, E. (2005) · Human Reproduction · doi:10.1093/humrep/dei135 · Cited by 1,584 · cited 1×
“The condition is typiWed by symptoms of pelvic pain, dysmenorrhoea, and dyspareunia, which are caused by peritoneal inXammation due to cyclic bleeding of endometriosis lesions [2, 3].”
BackgroundClassification and pharmacology of progestins
Schindler, A. E., Campagnoli, C., Druckmann, R., Huber, J., Pasqualini, J. R., Schweppe, K. W., & Thijssen, J. H. H. (2003) · Maturitas · doi:10.1016/j.maturitas.2003.09.014 · Cited by 745
Self-citationHarada, T., Momoeda, M., Taketani, Y., Aso, T., Fukunaga, M., Hagino, H., & Terakawa, N. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.12.080 · Cited by 279
Sasagawa, S., Shimizu, Y., Kami, H., Takeuchi, T., Mita, S., Imada, K., Kato, S., & Mizuguchi, K. (2008) · Steroids · doi:10.1016/j.steroids.2007.10.003 · Cited by 177
Köhler, G., Faustmann, T. A., Gerlinger, C., Seitz, C., & Mueck, A. O. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.08.020 · Cited by 159
Cosson, M., Querleu, D., Donnez, J., Madelenat, P., Konincks, P., Audebert, A., & Manhes, H. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03270-8 · Cited by 153
Pathophysiology, diagnosis and treatment of endometriosis.
Schindler, A. E. (2004) · PubMed · Cited by 139
Self-citationEffects of androgens on haemostasis
Winkler, U. H. (1996) · Maturitas · doi:10.1016/s0378-5122(96)82004-4 · Cited by 139
The influence of female sex steroids on glucose metabolism and insulin action.
Godsland, I. F. (1996) · PubMed · Cited by 112
Effect of four oral contraceptives on hemostatic parameters
Wiegratz, I., Lee, J. H., Kutschera, E., Winkler, U. H., & Kühl, H. (2004) · Contraception · doi:10.1016/j.contraception.2004.03.004 · Cited by 88
Selman, P. J., Mol, J. A., Rutteman, G. R., & Rijnberk, A. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1310413 · Cited by 83
Perspectives on the Women's Health Initiative trial of hormone replacement therapy
Grimes, D. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02503-6 · Cited by 78
High-dose pilot study with the novel progestogen dienogestin patients with endometriosis
Schindler, A. E., Christensen, B., Henkel, A., Oettel, M., & Moore, C. (2006) · Gynecological Endocrinology · doi:10.1080/09513590500431482 · Cited by 53 · cited 7×
“Participants were monitored at baseline and after 4, 12 and 24 weeks of treatment by gynaecological examination, transvaginal ultrasonography, breast ultrasonography and assessments of side eVects and the duration and intensity of vaginal bleeding (reported elsewhere) [15, 16].”
BackgroundMethodInfluentialSelf-citationLipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate
Fåhraeus, L., Sydsjö, A., & Wallentin, L. C. (1986) · Fertility and Sterility · doi:10.1016/s0015-0282(16)49277-0 · Cited by 47
Progestins: Present and future
Pasqualini, J. R. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00183-5 · Cited by 42
Palomba, S., Russo, T., Orio, F., Sammartino, A., Sbano, F. M., Nappi, C., Colao, A., Mastrantonio, P., Lombardi, G., & Zullo, F. (2004) · Human Reproduction · doi:10.1093/humrep/deh053 · Cited by 39
Telimaa, S., Apter, D. L., Reinilä, M., Rönnberg, L., & Kauppila, A. (1990) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(90)90055-6 · Cited by 30
Endometriosis in Clinical Practice
Markova, V., & Ianeva, R. (2004) · CRC Press eBooks · doi:10.3109/9780203319390 · Cited by 21
Winkler, U. H., Bühler, K. F., Koslowski, S., Oberhoff, C., & Schindler, A. E. (1992) · PubMed · Cited by 17
Self-citationInfluence of Esterified Estrogens and Medroxyprogesterone on Lipid Metabolism and Sex Steroids
Mattsson, L.-Å., Cullberg, G., & Samsioe, G. (1982) · Hormone and Metabolic Research · doi:10.1055/s-2007-1019092 · Cited by 16
Influence of oral contraceptive use on endothelial t-PA release in healthy premenopausal women
Hoetzer, G. L., Stauffer, B. L., Greiner, J. J., Casas, Y. G., Smith, D. T., & DeSouza, C. A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00333.2002 · Cited by 15
Schindler, A. E., Henkel, A., Christensen, B., Oettel, M., & Moore, C. (2009) · Gynecological Endocrinology · doi:10.1080/09513590902836536 · Cited by 15
Self-citation[Therapy of endometriosis with dienogest].
Köhler, G., Göretzlehner, G., & Amon, I. (1987) · PubMed · Cited by 15
Endometriosis in Clinical Practice
(1988) · Taylor & Francis eBooks · doi:10.4324/9780203319390 · Cited by 15
Differential effects of progestins
Schindler, A. E. (2003) · Maturitas · doi:10.1016/j.maturitas.2003.09.013 · Cited by 15
Self-citationPlasma lipoproteins during and after danazol treatment
Fåhraeus, L., Larsson‐Cohn, U., Ljungberg, S., & Wallentin, L. C. (1984) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348409157000 · Cited by 12
Hughes, J., & Mendelsohn, D. (1990) · PubMed · Cited by 5
Endometriosis is an Inflammatory Disease
MAHUTTE, N. G., Kayisli, U. A., & Arici, A. M. (2004) · CRC Press eBooks · doi:10.3109/9780203319390-13 · Cited by 5
Auswirkungen der Danazol-Therapie bei Endometriose auf Blutbild und Gerinnung
Schweppe, K.-W., Ebert, C., & Cirkel, U. (1988) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-2008-1026554 · Cited by 3
Research works printed but not linked: 2
- Oettel M, Carol W, Elger W (1995) A 19-norprogestin without 17β-ethinyl group II: dienogest from a pharmacodynamic point of view. Drugs Today 31:517–536
- Momoeda M, Taketani Y (2007) Randomized double-blind, multicentre, parallel-group dose–response study of dienogest in patients with endometriosis. Jpn Pharmacol Ther 35:769–783
Cited by
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment
Petraglia, F., Hornung, D., Seitz, C., Faustmann, T., Gerlinger, C., Luisi, S., Lazzeri, L., & Strowitzki, T. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1941-7 · Cited by 200
Dienogest in long-term treatment of endometriosis
Schindler, A. (2011) · International Journal of Women's Health · doi:10.2147/ijwh.s5633 · Cited by 158
Self-citationRuan, X., Seeger, H., & Mueck, A. O. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.01.018 · Cited by 143
Dienogest: A Review of its Use in the Treatment of Endometriosis
McCormack, P. L. (2010) · Drugs · doi:10.2165/11206320-000000000-00000 · Cited by 141
Strowitzki, T., Faustmann, T., Gerlinger, C., Schumacher, U., Ahlers, C., & Seitz, C. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s77202 · Cited by 120
“Even at a high dose of 20 mg/day for 24 weeks, dienogest had no clinically relevant impact on laboratory measures including glucose and lipid metabolism, liver function, electrolyte balance, and hematology.(28) Dienogest also demonstrates a well-characterized, favorable safety and tolerability profile in combination w…”
Metadata
- Authors
- Schindler, A. E., Henkel, A., Moore, C., & Oettel, M.
- Affiliations
- University of Duisburg-Essen (DE)
- St.-Johannes-Hospital Dortmund (DE)
- Corresponding author
- Schindler, Adolf E.
- Venue
- Archives of Gynecology and Obstetrics
- Published
- 2009-12-15
- Volume
- 282
- Issue
- 5
- Pages
- 507-514
- ISSN
- 0003-9128 (ISSN-L)
- 0932-0067
- 1432-0711
- OpenAlex
- W2023365171
- Cited by
- 36
- References
- 30
- Citations by year
- 2025: 1 · 2022: 1 · 2021: 1 · 2020: 4 · 2018: 1 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 5 · 2013: 4 · 2012: 4
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Gynecology and Obstetrics (publishedVersion)
- PubMed (publishedVersion)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- dienogest, endometriosis, drug safety, hemostasis, prothrombin fragment 1+2, antithrombin III, protein C, thyroid function, adrenal function, electrolyte balance, glycolipid metabolism, liver enzymes
- MeSH terms
- Adolescent, Adult, Antithrombin III, Cholesterol, Dose-Response Relationship, Drug, Endometriosis, Female, Hormone Antagonists, Humans, Middle Aged, Nandrolone, Peptide Fragments, Pilot Projects, Protein C, Prothrombin, Surveys and Questionnaires, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.